000			01764 a2200493 4500
005			20250515084244.0
264		0	_c20081103
008			200811s 0 0 eng d
022			_a1063-4584
024	7		_a10.1016/j.joca.2007.07.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aAuw Yang, K G
245	0	0	_aAutologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. _h[electronic resource]
260			_bOsteoarthritis and cartilage _cApr 2008
300			_a498-505 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aChondroitin Sulfates _xpharmacology
650	0	4	_aDisease Progression
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInjections, Intra-Articular
650	0	4	_aInterleukin 1 Receptor Antagonist Protein _xchemical synthesis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOsteoarthritis, Knee _xdrug therapy
650	0	4	_aPlacebos
650	0	4	_aProspective Studies
650	0	4	_aSeverity of Illness Index
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aRaijmakers, N J H
700	1		_avan Arkel, E R A
700	1		_aCaron, J J
700	1		_aRijk, P C
700	1		_aWillems, W J
700	1		_aZijl, J A C
700	1		_aVerbout, A J
700	1		_aDhert, W J A
700	1		_aSaris, D B F
773	0		_tOsteoarthritis and cartilage _gvol. 16 _gno. 4 _gp. 498-505
856	4	0	_uhttps://doi.org/10.1016/j.joca.2007.07.008 _zAvailable from publisher's website
999			_c17353889 _d17353889